[Other] Model-Informed Dosing Interval Extension of Infliximab in Patients With Inflammatory Bowel Diseases: Six Months Interim Analysis of the MODIFI Trial |
|
This post will be closed automatically in 2026-08-10 04:56
Reward20points
|
post
reply
points
30
20
Antioxidant and Apoptotic Effect of Edaravone on Cisplatin-Induced Brain Injury in Rats
20
Patient-Centered Pain Care Using Artificial Intelligence and Mobile Health Tools
50
The Effect of Lemon, Choline, and Coconut Oil on Obese Rats
20
Study of pharmaceutical interventions in the department of anesthesia and intensive care of the Habib Thameur hospital and their clinicals and economics impacts
20
Self-Directed vs Clinician-Delivered Cognitive Behavioral Therapy for Chronic Pain
